Find Pharmaceutical Logo stock video, 4K footage, and other HD footage from iStock. Get higher quality Pharmaceutical Logo content, for less—All of our 4K video clips are the same price as HD. Video ...

Rhythm Pharmaceuticals (RYTM) announced that it reacquired the rights to Imcivree in China, including mainland China, Hong Kong and Macau, as ...

Under the agreement, Rhythm has agreed to repay $6.3 million in cash to RareStone. Rhythm also agreed to return all shares of RareStone that were acquired under the original agreement for no ...

Rhythm Pharmaceuticals had a negative net margin of 230.07% and a negative return on equity of 367.36%. The company had revenue of $41.83 million during the quarter, compared to analyst estimates ...

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.72 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.70 per share a year ago.

Shares of RYTM opened at $53.22 on Monday. Rhythm Pharmaceuticals has a 52 week low of $35.17 and a 52 week high of $68.58. The firm has a market cap of $3.27 billion, a price-to-earnings ratio of ...

The image below shows how its cash balance has been changing over the last few years. At first glance it's a bit worrying to see that Rhythm Pharmaceuticals actually boosted its cash burn by 16% ...

Good day, and welcome to Rhythm Pharmaceuticals Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

Importantly, analysts think that Rhythm Pharmaceuticals will reach cashflow breakeven in 3 years. That means unless the company reduces its cash burn quickly, it may well look to raise more cash. The ...

Rhythm Pharmaceuticals (RYTM) has disclosed a new risk, in the Share Price & Shareholder Rights category. Rhythm Pharmaceuticals faces a business ...

David Meeker; Chairman of the Board, President, Chief Executive Officer; Rhythm Pharmaceuticals Inc Jennifer Lee; Executive Vice President, Head of North America; Rhythm Pharmaceuticals Inc Yann ...